Retrospective Study
Copyright ©The Author(s) 2025.
World J Gastroenterol. Apr 28, 2025; 31(16): 105985
Published online Apr 28, 2025. doi: 10.3748/wjg.v31.i16.105985
Figure 4
Figure 4 Linear discriminant analysis effect size analysis identified differential microbiota in hepatic fibrosis patients. A and B: Differential microbiota in hepatic fibrosis (HF) and non-HF groups; C and D: Differential microbiota in mild HF and significant HF groups; E and F: Differential microbiota in different fibrosis stages (F1, F2, F3, and F4). All data were analyzed by linear discriminant analysis effect size analysis (linear discriminant analysis > 2, P < 0.05). LDA: Linear discriminant analysis; HF: Hepatic fibrosis; mHF: Mild hepatic fibrosis; sHF: Significant hepatic fibrosis.